Product Name | Emtricitabine (BW1592) |
---|---|
CAS | 143491-57-0 |
Formula | C8H10FN3O3S |
MW | 247.25 |
Appearance | White to off-white powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
500 mg | 3-5days | ¥350.00 | Visible after login | |
1 g | 3-5days | ¥660.00 | Visible after login | |
5 g | 3-5days | ¥1150.00 | Visible after login |
Product Name | Emtricitabine (BW1592) |
---|---|
CAS | 143491-57-0 |
Formula | C8H10FN3O3S |
MW | 247.25 |
Appearance | White to off-white powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Emtricitabine (BW1592; FTC; Coviracil; Emtriva; Racivir) is a potent nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 µM and has been used for the treatment of both human immunodeficiency virus (HIV) and hepatitis B virus. Emtricitabine is structurally similar to Lamivudine. It is effective at targeting HIV and HBV viruses since these viruses replicate in a reverse transcriptase manner. Studies indicate that the structure of Emtricitabine, specifically the unnatural β-L structural configuration produce greater antiviral effects in vitro on HIV and HBV than other antiviral agents. nucleoside reverse transcriptase inhibitor.